Active autoantibody-positive Systemic lupus erythematosus
Understanding Active Autoantibody-Positive Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder characterized by inflammation and tissue damage in multiple organ systems, including the brain, skin, kidneys, and joints. It is a potentially serious condition that affects an estimated 1.5 million Americans.
The most common form of SLE is called active autoantibody-positive SLE. In this form of the disease, the patient’s body produces antibodies, known as autoantibodies, that target and damage its own proteins and tissue. This leads to inflammation, tissue damage, and other symptoms of the disease.
Symptoms of Active Autoantibody-Positive Systemic Lupus Erythematosus
The symptoms of active autoantibody-positive SLE can vary from person to person and can change over time. Common symptoms of the disease include:
- Fatigue
- Joint pain and swelling
- Skin rash, especially on the face and scalp
- Hair loss
- Fever and other flu-like symptoms
- Mouth ulcers
- Sensitivity to the sun
- Chest pain
The symptoms of active autoantibody-positive SLE can be managed with medications, lifestyle changes, and other treatments.
Diagnosis and Treatment of Active Autoantibody-Positive Systemic Lupus Erythematosus
If you are experiencing any of the symptoms of active autoantibody-positive SLE, it’s important to speak with your doctor. They can provide a diagnosis and recommend a treatment plan that is best for your unique needs.
Treatment for active autoantibody-positive SLE may include medications to reduce inflammation, pain medications, and lifestyle changes to reduce fatigue and other symptoms. In some cases, your doctor may recommend counseling or therapy to help cope with the emotional effects of the disease.
It is also important to communicate with your doctor if you are experiencing any side effects from the medications you are taking. Your doctor can work with you to adjust your treatment plan to minimize any potential side effects.